In any case where immunity to SARS-CoV-2 isn't permanent, the virus is capable of producing sporadic outbreaks. If the duration of the immunity is less than a year, the outbreaks will be annual.

Building a 3-D model of a complete virus like SARS-CoV-2 in molecular detail requires a mix of research, hypothesis and artistic license. Some structures are known, others are somewhat known, and ...

The model predicts that the infection fatality ratio for SARS-CoV-2 may fall below that of seasonal influenza (0.1 percent), once an endemic steady-state is reached.

Dutch researchers have built a three-dimensional model of a type of virus that causes SARS in a step that could one day help in the battle against the deadly disease. IE 11 is not supported.

A promising path to fighting COVID and other coronaviruses may have been based on a serious mistake. Scientists had zeroed in ...

The SARS-CoV-2 virus model is a part of Visual Science's non-commercial Viral Park project. Its past successes include models of HIV, influenza A/H1N1, Ebola, papilloma, and Zika virions.

The SARS-CoV-2 virus model is a part of Visual Science's non-commercial Viral Park project. Its past successes include models of HIV, influenza A/H1N1, Ebola, papilloma, and Zika virions.

AI model provides clues about how a virus may evolve and the immune response it could provoke. ... However, five years later, SARS-CoV-2 is still circulating, and in the process, ...

Using nose organoids, which model the complex interactions between human cells and virus, the team showed key differences between the infection by SARS-CoV-2, the virus that causes COVID-19, and that ...

Using the HNO model, the team of researchers showed key differences between the infection caused by SARS-CoV-2 and that of RSV, a major pediatric respiratory virus.

An in vitro model of the human lung airway epithelium developed by Newcells Biotech is currently being tested as a platform for modeling SARS-CoV-2 infection. To learn more about the model and how it ...